Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-01-04 Christmas Patrick J. SVP, General Counsel Grant or award · Stock Option (Right to Buy) +11,100 11,100
2017-01-04 Ali Faraz Chief Business Officer Grant or award · Stock Option (Right to Buy) +25,200 25,200
2017-01-04 Mills Kenneth T. President and CEO Grant or award · Stock Option (Right to Buy) +130,000 130,000
2017-01-04 Yoo Stephen Chief Medical Officer Grant or award · Stock Option (Right to Buy) +40,000 40,000
2017-01-04 Simpson Curran SVP, Technical Operations Grant or award · Stock Option (Right to Buy) +30,000 30,000
2017-01-04 Vasista Vittal Chief Financial Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2016-12-31 Vasista Vittal Chief Financial Officer Grant or award +1,372 $6.79 $9K 116,812
2016-12-08 Simpson Curran SVP, Technical Operations Grant or award +39,500 39,500
2016-08-18 Christmas Patrick J. Senior VP, General Counsel Grant or award · Employee Stock Option (Right to Buy) +125,000 125,000
2016-08-15 Tasse Daniel Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2016-08-05 Abdun-Nabi Daniel Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2016-06-13 Mills Kenneth T. President and CEO Exercise or conversion +125,000 $0.85 $106K 140,440
2016-06-13 Mills Kenneth T. President and CEO Exercise or conversion · Employee Stock Option (Right to Buy) −125,000 583,200
2016-06-01 STUMP DAVID C Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2016-06-01 KARABELAS ARGERIS N Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2016-06-01 BESHAR LUKE M Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2016-06-01 Samuels Camille D Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2016-06-01 HAYDEN DONALD J JR Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2016-06-01 Fox Allan M. Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2016-05-17 FMR LLC Sale −18,300 $12.41 $227K 619,376

Page 49 of 56 · 1,104 trades